FMCG · NSE: MANORAMA
Manorama Industries
Q2 FY27 earnings highlights, from the results presentation
Q2 FY27 · From the investor presentation
- M.Cap
- ₹11,861Cr
- P/E
- 41.7×
- 1Y return
- +41.36%
- From 52W high
- −13.1%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 459 | 323 | +41.9% | 404 | +13.6% |
| EBITDA | 118 | 88 | +34.4% | 106 | +11.3% |
| EBITDA margin | 25.8% | 27.2% | -143 bps | 26.3% | -53 bps |
| PBTProfit before tax | 110 | 73 | +50.5% | 106 | +3.6% |
| Net profit | 81 | 53 | +51.8% | 79 | +2.7% |
| EPS (₹) | 12.44 | 8.91 | +39.6% | 13.17 | -5.5% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures. In Q2 FY27 the filing tags the owners' profit as ₹0 Cr against its own period profit; the period profit less minority interest is shown.
More figures from the presentation
“shea-growing regions with the objective of reaching up to 100,000 beneficiaries through”
In short
- 01Q2 FY27 revenue grew 41.9% YoY.
- 02Q2 FY27 EBITDA rose 34.4% to Rs 1,182 million and PAT rose 51.8%.
- 03H1 FY27 revenue grew 40.8% and PAT grew 59.2%, attributed to demand and a stronger value-added mix.
- 04Gross margin fell 577 bps YoY to 42.5% and EBITDA margin was 25.8% in Q2 FY27.
- 05Exports were 61% of H1 FY27 revenue.
- 06Planned capex over the next 2-3 years covers fractionation debottlenecking and refining, with FY28 target commissioning.
Capex
Plan to add refining capability as forward integration
Slides · p. 23
Plan to add refining capability as forward integration
“02 Scale Refining Add refining capability (forward-integration program)”
FY28 target commissioning for the major projects
Slides · p. 23
FY28 target commissioning for the major projects
“FY28 target commissioning”
Newly acquired land for capex
Slides · p. 22
Newly acquired land for capex
“NEWLY ACQUIRED LAND FOR CAPEX”
Proposed capex is subject to Board recommended modifications
Slides · p. 23
Proposed capex is subject to Board recommended modifications
“^ Subject to Board Recommended Modifications”
Capacity
Segments
Export: Domestic to export revenue mix for H1 FY27 was 39:61
Slides · p. 6
Export: Domestic to export revenue mix for H1 FY27 was 39:61
“Geographical Mix: The Domestic to Export Revenue Mix for H1FY27 stood at 39:61.”
Plan to raise share of CBE, stearin, specialty fats and value-added formulations
Slides · p. 23
Plan to raise share of CBE, stearin, specialty fats and value-added formulations
“Increase contribution from CBE, stearin, specialty fats and application-specific,”
Stearin & CBE: Stearin and CBE were 71.4% of FY26 revenue
Slides · p. 16
Stearin & CBE: Stearin and CBE were 71.4% of FY26 revenue
“71.4% 2 Decades Fortune 500 FY26 - Stearin & CBE”
Demand
Company cites demand drivers for its specialty fats business
Slides · p. 19
Company cites demand drivers for its specialty fats business
“Strong demand drivers underpin Manorama’s integrated specialty fats proposition”
Margins and costs
Q2 gross margin 42.5% vs 48.3% a year ago, down 577 bps
Slides · p. 7
Q2 gross margin 42.5% vs 48.3% a year ago, down 577 bps
“Gross Profit margin 42.5% 48.3% -577 bps 43.6% -109 bps 43.0% 47.9% -482 bps 46.3%”
Q2 EBITDA margin 25.8% vs 27.2% a year ago, down 144 bps
Slides · p. 7
Q2 EBITDA margin 25.8% vs 27.2% a year ago, down 144 bps
“EBITDA margin 25.8% 27.2% -144 bps 26.3% -53 bps 26.0% 26.5% -53 bps 26.4%”
Q2 PAT margin 17.6% vs 16.5% a year ago, up 114 bps
Slides · p. 7
Q2 PAT margin 17.6% vs 16.5% a year ago, up 114 bps
“PAT margin 17.6% 16.5% 114 bps 19.5% -186 bps 18.5% 16.3% 213 bps 16.5%”
Q2 employee expenses INR 216.8 million, up 49.3% YoY
Slides · p. 7
Q2 employee expenses INR 216.8 million, up 49.3% YoY
“Employee Expenses 216.8 145.2 49.3% 188.6 14.9% 405.4 328.3 23.5% 723.1”
Debt and working capital
Q2 finance cost INR 113.8 million, up 30.5% YoY
Slides · p. 7
Q2 finance cost INR 113.8 million, up 30.5% YoY
“Finance Cost 113.8 87.2 30.5% 99.0 15.0% 212.8 179.7 18.4% 378.7”
Consolidated total equity INR 13,280 million vs 6,821 million in March
Slides · p. 8
Consolidated total equity INR 13,280 million vs 6,821 million in March
“Total Equity 13,280 6,821”
Consolidated current borrowings INR 4,863 million vs 3,218 million in March
Slides · p. 8
Consolidated current borrowings INR 4,863 million vs 3,218 million in March
“Borrowings 4,863 3,218 Other Bank Balances”
Consolidated inventories INR 10,012 million vs 7,278 million in March
Slides · p. 8
Consolidated inventories INR 10,012 million vs 7,278 million in March
“Inventories 10,012 7,278”
Consolidated trade receivables INR 1,135 million vs 625 million in March
Slides · p. 8
Consolidated trade receivables INR 1,135 million vs 625 million in March
“Trade Receivables 1,135 625”
Management
Leadership transition described as strengthening governance and management structure
Slides · p. 5
Leadership transition described as strengthening governance and management structure
“The leadership transition strengthens Manorama Industries governance and management”
Mudit Kumar Singh listed as Chairman and Whole Time Director
Slides · p. 30
Mudit Kumar Singh listed as Chairman and Whole Time Director
“Mudit Kumar Singh – Chairman & Whole Time Director”
One-offs
Q2 other income INR 96.9 million vs 0.8 million a year ago
Slides · p. 7
Q2 other income INR 96.9 million vs 0.8 million a year ago
“Other Income 96.9 0.8 12,222.0% 161.8 -40.1% 258.7 58.4 342.7% 103.5”
Other
Q2 FY27 revenue grew 41.9% YoY
Slides · p. 5
Q2 FY27 revenue grew 41.9% YoY
“We are pleased to report another strong quarter, with Q2FY27 revenue growing 41.9% YoY to”
Q2 EBITDA up 34.4% to ₹1,182 million; PAT up 51.8% to ₹808 million
Slides · p. 5
Q2 EBITDA up 34.4% to ₹1,182 million; PAT up 51.8% to ₹808 million
“₹4,589 million, EBITDA rising 34.4% to ₹1,182 million and PAT increasing 51.8% to ₹808”
H1 FY27 revenue grew 40.8%
Slides · p. 5
H1 FY27 revenue grew 40.8%
“million. H1FY27 performance remained equally robust, with revenue growth of 40.8% and PAT”
H1 PAT growth of 59.2% attributed to demand, value-added mix and execution
Slides · p. 5
H1 PAT growth of 59.2% attributed to demand, value-added mix and execution
“growth of 59.2%, driven by healthy demand, a stronger value-added mix and disciplined”
Q2 diluted EPS INR 12.44 vs 8.91 a year ago
Slides · p. 7
Q2 diluted EPS INR 12.44 vs 8.91 a year ago
“Diluted EPS (in INR) 12.44 8.91 39.6% 13.17 -5.5% 25.61 16.77 52.7% 37.66”
Sources
- Investor presentation, Q2 FY27 Filed 12 Nov 2026 · 44 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

